Among the 45 genetically tested CVID patients (75.6% of the total CVID cohort), only one individual harbored a confirmed pathogenic variant (in PIK3R1), while the remaining cases predominantly involved VUS in genes such as TNFRSF13B, CR2, and PI3KCG. This evidence concerns the gene TNFRSF13B and common variable immunodeficiency.